Abstract
This chapter will review the epidemiology, clinical presentation, recommended evaluation and treatment of Central Nervous System (CNS) infections associated with HIV infection and Neurocysticercosis (NCC). HIV infection is frequently complicated by opportunistic infection or neoplasm of the CNS. NCC, a parasitic infection of the CNS, is the most common cause of epilepsy in the developing world and may present clinically as obstructive hydrocephalus. Most opportunistic CNS infections and neoplasms are associated with headache, fever, meningismus, altered level of consciousness, or focal neurologic deficit. NCC is diagnosed by neuroimaging and serologic testing. Treatment of these CNS infections is mainly medical, but can include surgery for diagnostic purposes and surgical removal of lesions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475–95.
Bacellar H, Munoz A, Miller EN et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology 1994;44:1892–900.
Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV. The neuropathology of AIDS: UCLA experience and review. Am J Pathol. 1986;124:537–58.
Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000;69:376–80.
Luft BJ, Remington JS. AIDS commentary: toxoplasmic encephalitis. J Infect Dis 1988;157:1–6.
Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994;18:789–92.
Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993;342:398–401.
McGuire D, Barhite S, Hollander H, Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy [published erratum appears in Ann Neurol 1995;37:687]. Ann Neurol 1995;37:395–9.
Evaluation and management of intracranial mass lesions in AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology [see comments]. Neurology 1998;50:21–6.
Gildenberg PL, Gathe JC Jr, Kim JH. Stereotactic biopsy of cerebral lesions in AIDS. Clin Infect Dis 2000;30:491–9.
Feiden W, Bise K, Steude U, Pfister HW, Moller AA. The stereotactic biopsy diagnosis of focal intracerebral lesions in AIDS patients. Acta Neurol Scand 1993;87:228–33.
Hornef MW, Iten A, Maeder P, Villemure JG, Regli L. Brain biopsy in patients with acquired immunodeficiency syndrome: diagnostic value, clinical performance, and survival time. Arch Intern Med 1999;159:2590–6.
Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bull World Health Organ 1993;71:247–58.
Pittella JE. Neurocysticercosis. Brain Pathol 1997;7:681–93.
Schantz PM, McAuley J. Current status of food-borne parasitic zoonoses in the United States. Southeast Asian J Trop Med Public Health 1991;22 (Suppl.): 65–71.
Ehnert KL, Roberto RR, Barrett L, Sorvillo FJ, Rutherford GWd. Cysticercosis: first 12 months of reporting in California. Bull Pan Am Health Organ 1992;26:165–72.
Moore AC, Lutwick LI, Schantz PM. Seroprevalence of cysticercosis in an Orthodox Jewish community. Am J Trop Med Hyg 1995;53:439–42.
Cantu C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis: clinical and neuroimaging spectrum. Arch Neurol 1996;53:233–9.
Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis [see comments]. J Neurol Sci 1996;142:1–6.
Rodriguez-Carbajal J, palacios E, Zee CS. Neuroradiology of cysticercosis of the central nervous system. In: Palacios E, Rodriguez-Carbajal J, Taveras JM et al., editors. Cysticercosis of the central nervous system. Springfield, IL: Charles C. Thomas, 1983;101–43.
Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras JM. Cysticercosis of the nervous system. Springfield, IL: Charles C. Thomas, 1983.
Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992;49:290–4.
Jung H, Hurtado M, Medina MT, Sanchez M, Sotelo J. Dexamethasone increases plasma levels of albendazole. J Neurol 1990;237:279–80.
Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis [see comments]. N Engl J Med 1992;327:696–701.
Apuzzo ML, Dobkin WR, Zee CS, Chan JC, Giannotta SL, Weiss MH. Surgical considerations in treatment of intraventricular cysticercosis: an analysis of 45 cases. J Neurosurg 1984;60:400–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Zunt, J.R. (2005). Infections in the Central Nervous System. In: Moore, A.J., Newell, D.W. (eds) Neurosurgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/1-84628-051-6_36
Download citation
DOI: https://doi.org/10.1007/1-84628-051-6_36
Publisher Name: Springer, London
Print ISBN: 978-1-85233-522-9
Online ISBN: 978-1-84628-051-1
eBook Packages: MedicineMedicine (R0)